QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||
(Address of principal executive offices) | (Zip Code) | ||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
☒ | Accelerated filer | ☐ | ||||
Non-accelerated filer | ☐ | Smaller reporting company | ||||
Emerging growth company |
PART I. FINANCIAL INFORMATION | |
Page | |
Consolidated Statements of Financial Condition (Unaudited) ......................................................................................................... | |
Consolidated Statements of Earnings (Unaudited) ............................................................................................................................ | |
Consolidated Statements of Comprehensive Income (Unaudited) .................................................................................................. | |
Consolidated Statements of Changes in Equity (Unaudited) ............................................................................................................ | |
Consolidated Statements of Cash Flows (Unaudited) ....................................................................................................................... | |
Notes to Consolidated Financial Statements (Unaudited) ................................................................................................................ | |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations ............................................... | |
Item 3. Quantitative and Qualitative Disclosures About Market Risk .................................................................................................... | |
Item 4. Controls and Procedures .................................................................................................................................................................. | |
PART II. OTHER INFORMATION | |
Item 1. Legal Proceedings ............................................................................................................................................................................. | |
Item 1A. Risk Factors ..................................................................................................................................................................................... | |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds .................................................................................................. | |
Item 5. Other Information .............................................................................................................................................................................. | |
Item 6. Exhibits ................................................................................................................................................................................................ | |
2 | Jefferies Financial Group Inc. |
Consolidated Statements of Financial Condition (Unaudited) | ||
$ in thousands, except share and per share amounts | February 28, 2025 | November 30, 2024 |
Assets | ||
Cash and cash equivalents .............................................................................................................................................................. | $ | $ |
Cash and securities segregated and on deposit for regulatory purposes or deposited with clearing and depository organizations (includes $ | ||
Financial instruments owned, at fair value (includes securities pledged of $ | ||
Investments in and loans to related parties .................................................................................................................................. | ||
Securities borrowed .......................................................................................................................................................................... | ||
Securities purchased under agreements to resell ........................................................................................................................ | ||
Securities received as collateral, at fair value ............................................................................................................................... | ||
Receivables: | ||
Brokers, dealers and clearing organizations .............................................................................................................................. | ||
Customers ....................................................................................................................................................................................... | ||
Fees, interest and other ................................................................................................................................................................. | ||
Premises and equipment .................................................................................................................................................................. | ||
Goodwill .............................................................................................................................................................................................. | ||
Assets held for sale ........................................................................................................................................................................... | ||
Other assets (includes assets pledged of $ | ||
Total assets ........................................................................................................................................................................................ | $ | $ |
Liabilities and Equity | ||
Short-term borrowings ...................................................................................................................................................................... | $ | $ |
Financial instruments sold, not yet purchased, at fair value ....................................................................................................... | ||
Securities loaned ............................................................................................................................................................................... | ||
Securities sold under agreements to repurchase ......................................................................................................................... | ||
Other secured financings (includes $ | ||
Obligation to return securities received as collateral, at fair value ............................................................................................ | ||
Payables: | ||
Brokers, dealers and clearing organizations .............................................................................................................................. | ||
Customers ....................................................................................................................................................................................... | ||
Lease liabilities .................................................................................................................................................................................. | ||
Accrued expenses and other liabilities ........................................................................................................................................... | ||
Long-term debt (includes $ | ||
Total liabilities ................................................................................................................................................................................... | ||
Mezzanine Equity | ||
Redeemable noncontrolling interests ............................................................................................................................................. | ||
Equity | ||
Preferred shares, par value of $ liquidation preference of $ | ||
Common shares, par value $ issued and outstanding, after deducting | ||
Non-voting common shares, par value $ outstanding .................................................................................................................................................................................... | ||
Additional paid-in capital .................................................................................................................................................................. | ||
Accumulated other comprehensive loss ....................................................................................................................................... | ( | ( |
Retained earnings .............................................................................................................................................................................. | ||
Total Jefferies Financial Group Inc. shareholders' equity ......................................................................................................... | ||
Noncontrolling interests ................................................................................................................................................................... | ||
Total equity ........................................................................................................................................................................................ | ||
Total liabilities and equity ............................................................................................................................................................... | $ | $ |
February 2025 Form 10-Q | 3 |
$ in thousands, except per share amounts | Three Months Ended | ||
February 28, 2025 | February 29, 2024 | ||
Revenues | |||
Investment banking ................................................................................................................................................................... | $ | $ | |
Principal transactions ............................................................................................................................................................... | |||
Commissions and other fees .................................................................................................................................................. | |||
Asset management fees and revenues ................................................................................................................................. | |||
Interest ........................................................................................................................................................................................ | |||
Other ............................................................................................................................................................................................ | |||
Total revenues ........................................................................................................................................................................... | |||
Interest expense ........................................................................................................................................................................ | |||
Net revenues .............................................................................................................................................................................. | |||
Non-interest expenses | |||
Compensation and benefits ..................................................................................................................................................... | |||
Brokerage and clearing fees .................................................................................................................................................... | |||
Underwriting costs .................................................................................................................................................................... | |||
Technology and communications .......................................................................................................................................... | |||
Occupancy and equipment rental ........................................................................................................................................... | |||
Business development ............................................................................................................................................................. | |||
Professional services ............................................................................................................................................................... | |||
Depreciation and amortization ................................................................................................................................................ | |||
Cost of sales .............................................................................................................................................................................. | |||
Other expenses .......................................................................................................................................................................... | |||
Total non-interest expenses ................................................................................................................................................... | |||
Earnings from continuing operations before income taxes ................................................................................................ | |||
Income tax expense .................................................................................................................................................................. | |||
Net earnings from continuing operations .............................................................................................................................. | |||
Net losses from discontinued operations, net of income tax benefit of $ | ( | ||
Net earnings ............................................................................................................................................................................... | |||
Net losses attributable to noncontrolling interests .............................................................................................................. | ( | ( | |
Preferred stock dividends ........................................................................................................................................................ | |||
Net earnings attributable to common shareholders ........................................................................................................... | $ | $ | |
Earnings per common share | |||
Basic from continuing operations ........................................................................................................................................... | $ | $ | |
Diluted from continuing operations ........................................................................................................................................ | |||
Basic ............................................................................................................................................................................................ | |||
Diluted ......................................................................................................................................................................................... | |||
Weighted-average common shares outstanding ................................................................................................................ | |||
Basic ............................................................................................................................................................................................ | |||
Diluted ......................................................................................................................................................................................... | |||
4 | Jefferies Financial Group Inc. |
$ in thousands | Three Months Ended | ||
February 28, 2025 | February 29, 2024 | ||
Net earnings .................................................................................................................................................................................. | $ | $ | |
Other comprehensive income (loss), net of tax: | |||
Currency translation adjustments and other (1) ..................................................................................................................... | ( | ( | |
Changes in fair value related to instrument-specific credit risk (2) ...................................................................................... | ( | ||
Unrealized gains on available-for-sale-securities ................................................................................................................... | |||
Total other comprehensive income (loss), net of tax (3) ...................................................................................................... | ( | ||
Comprehensive income ............................................................................................................................................................... | |||
Net losses attributable to noncontrolling interests ................................................................................................................. | ( | ( | |
Preferred stock dividends ............................................................................................................................................................ | |||
Comprehensive income attributable to common shareholders ........................................................................................... | $ | $ | |
February 2025 Form 10-Q | 5 |
$ in thousands | Three Months Ended | ||
February 28, 2025 | February 29, 2024 | ||
Preferred shares $1 par value | |||
Balance, beginning of period .................................................................................................................................................... | $ | $ | |
Balance, end of period .............................................................................................................................................................. | $ | $ | |
Common shares $1 par value | |||
Balance, beginning of period .................................................................................................................................................... | $ | $ | |
Purchase of common shares for treasury .......................................................................................................................... | ( | ( | |
Other ......................................................................................................................................................................................... | |||
Balance, end of period .............................................................................................................................................................. | $ | $ | |
Additional paid-in capital | |||
Balance, beginning of period .................................................................................................................................................... | $ | $ | |
Share-based compensation expense .................................................................................................................................. | |||
Purchase of common shares for treasury .......................................................................................................................... | ( | ( | |
Dividend equivalents .............................................................................................................................................................. | |||
Change in equity interest related to consolidated subsidiaries ....................................................................................... | — | ||
Other ......................................................................................................................................................................................... | ( | ||
Balance, end of period .............................................................................................................................................................. | $ | $ | |
Accumulated other comprehensive loss, net of tax | |||
Balance, beginning of period .................................................................................................................................................... | $( | $( | |
Other comprehensive income (loss), net of taxes ............................................................................................................. | ( | ||
Balance, end of period .............................................................................................................................................................. | $( | $( | |
Retained earnings | |||
Balance, beginning of period .................................................................................................................................................... | $ | $ | |
Net earnings attributable to Jefferies Financial Group Inc. .............................................................................................. | |||
Dividends - common shares ($ | ( | ( | |
Dividends - preferred shares ................................................................................................................................................. | ( | ( | |
Cumulative effect of change in accounting principle for current expected credit losses, net of tax ......................... | — | ( | |
Other ......................................................................................................................................................................................... | — | ( | |
Balance, end of period .............................................................................................................................................................. | $ | $ | |
Total Jefferies Financial Group Inc. shareholders' equity ................................................................................................. | $ | $ | |
Noncontrolling interests | |||
Balance, beginning of period .................................................................................................................................................... | $ | $ | |
Net losses attributable to noncontrolling interests ........................................................................................................... | ( | ( | |
Contributions ........................................................................................................................................................................... | |||
Distributions ............................................................................................................................................................................ | ( | ( | |
Change in equity interest related to consolidated subsidiaries ....................................................................................... | ( | — | |
Other ......................................................................................................................................................................................... | |||
Balance, end of period .............................................................................................................................................................. | $ | $ | |
Total equity ................................................................................................................................................................................. | $ | $ | |
6 | Jefferies Financial Group Inc. |
$ in thousands | Three Months Ended | |
February 28, 2025 | February 29, 2024 | |
Cash flows from operating activities: | ||
Net earnings ...................................................................................................................................................................................... | $ | $ |
Adjustments to reconcile net earnings to net cash used in operating activities: | ||
Depreciation and amortization .................................................................................................................................................... | ||
Share-based compensation ......................................................................................................................................................... | ||
Net bad debt expense ................................................................................................................................................................... | ||
Income on investments in and loans to related parties ........................................................................................................... | ( | ( |
Distributions received on investments in related parties ........................................................................................................ | ||
Other adjustments ......................................................................................................................................................................... | ( | |
Net change in assets and liabilities: | ||
Receivables: | ||
Brokers, dealers and clearing organizations .......................................................................................................................... | ( | ( |
Customers ................................................................................................................................................................................... | ( | |
Fees, interest and other ............................................................................................................................................................. | ( | ( |
Securities borrowed ...................................................................................................................................................................... | ( | |
Financial instruments owned ....................................................................................................................................................... | ( | ( |
Securities purchased under agreements to resell .................................................................................................................... | ( | ( |
Other assets ................................................................................................................................................................................... | ( | ( |
Payables: | ||
Brokers, dealers and clearing organizations .......................................................................................................................... | ||
Customers ................................................................................................................................................................................... | ||
Securities loaned ........................................................................................................................................................................... | ( | |
Financial instruments sold, not yet purchased ......................................................................................................................... | ||
Securities sold under agreements to repurchase ..................................................................................................................... | ||
Lease liabilities .............................................................................................................................................................................. | ( | ( |
Accrued expenses and other liabilities ...................................................................................................................................... | ( | ( |
Net cash used in operating activities from continuing operations ......................................................................................... | ( | ( |
Net cash provided by (used in) operating activities from discontinued operations ............................................................ | ( | |
Cash flows from investing activities: | ||
Contributions to investments in and loans to related parties ................................................................................................. | ( | ( |
Capital distributions from investments and repayments of loans from related parties ..................................................... | ||
Originations and purchases of automobile loans, notes and other receivables .................................................................. | ( | |
Principal collections of automobile loans, notes and other receivables ............................................................................... | ||
Net payments on premises and equipment .............................................................................................................................. | ( | ( |
Net cash used in investing activities from continuing operations .......................................................................................... | ( | ( |
February 2025 Form 10-Q | 7 |
$ in thousands | Three Months Ended | |
February 28, 2025 | February 29, 2024 | |
Cash flows from financing activities: | ||
Proceeds from short-term borrowings ....................................................................................................................................... | $ | $ |
Payments on short-term borrowings .......................................................................................................................................... | ( | ( |
Proceeds from issuance of long-term debt, net of issuance costs ....................................................................................... | ||
Repayment of long-term debt ...................................................................................................................................................... | ( | ( |
Purchase of common shares for treasury ................................................................................................................................. | ( | ( |
Dividends paid to common and preferred shareholders ......................................................................................................... | ( | ( |
Net proceeds from other secured financings ........................................................................................................................... | ||
Net change in bank overdrafts .................................................................................................................................................... | ( | |
Proceeds from contributions of noncontrolling interests ....................................................................................................... | ||
Payments on distributions to noncontrolling interests ............................................................................................................ | ( | ( |
Other ................................................................................................................................................................................................ | ||
Net cash provided by financing activities from continuing operations .................................................................................. | ||
Net cash provided by (used in) financing activities from discontinued operations ............................................................. | ( | |
Effect of exchange rate changes on cash, cash equivalents, and restricted cash ............................................................... | ( | ( |
Change in cash, cash equivalents, and restricted cash reclassified from (to) assets held for sale .................................... | ( | |
Net decrease in cash, cash equivalents, and restricted cash .................................................................................................... | ( | ( |
Cash, cash equivalents, and restricted cash at beginning of period ........................................................................................ | ||
Cash, cash equivalents, and restricted cash at end of period .................................................................................................. | $ | $ |
Supplemental disclosures of cash flow information: | ||
Cash paid during the period for: | ||
Interest ............................................................................................................................................................................................ | $ | $ |
Income taxes, net .......................................................................................................................................................................... | ||
February 28, | November 30, | |
$ in thousands | 2025 | 2024 |
Cash and cash equivalents ........................................................................................................................................... | $ | $ |
Cash on deposit for regulatory purposes with clearing and depository organizations ....................................... | ||
Total cash, cash equivalents and restricted cash .................................................................................................... | $ | $ |
8 | Jefferies Financial Group Inc. |
Page | |
Note 1. Organization and Basis of Presentation ...................................................................................................................................................................... | |
Note 2. Summary of Significant Accounting Policies ............................................................................................................................................................. | |
Note 3. Accounting Developments ............................................................................................................................................................................................ | |
Note 4. Business Acquisitions .................................................................................................................................................................................................... | |
Note 5. Assets Held for Sale and Discontinued Operations ................................................................................................................................................... | |
Note 6. Fair Value Disclosures .................................................................................................................................................................................................... | |
Note 7. Derivative Financial Instruments .................................................................................................................................................................................. | |
Note 8. Collateralized Transactions ........................................................................................................................................................................................... | |
Note 9. Securitization Activities ................................................................................................................................................................................................. | |
Note 10. Variable Interest Entities .............................................................................................................................................................................................. | |
Note 11. Investments ................................................................................................................................................................................................................... | |
Note 12. Credit Losses on Financial Assets Measured at Amortized Cost ......................................................................................................................... | |
Note 13. Goodwill and Intangible Assets .................................................................................................................................................................................. | |
Note 14. Revenues from Contracts with Customers ............................................................................................................................................................... | |
Note 15. Compensation Plans .................................................................................................................................................................................................... | |
Note 16. Borrowings ..................................................................................................................................................................................................................... | |
Note 17. Total Equity .................................................................................................................................................................................................................... | |
Note 18. Income Taxes ................................................................................................................................................................................................................ | |
Note 19. Commitments, Contingencies and Guarantees ....................................................................................................................................................... | |
Note 20. Regulatory Requirements ............................................................................................................................................................................................ | |
Note 21. Segment Reporting ....................................................................................................................................................................................................... | |
Note 22. Related Party Transactions ......................................................................................................................................................................................... |
February 2025 Form 10-Q | 9 |
10 | Jefferies Financial Group Inc. |
February 2025 Form 10-Q | 11 |
12 | Jefferies Financial Group Inc. |
February 28, 2025 (1) | |||||
$ in thousands | Level 1 | Level 2 | Level 3 | Counterparty and Cash Collateral Netting (2) | Total |
Assets: | |||||
Financial instruments owned: | |||||
Corporate equity securities ................................................................................ | $ | $ | $ | $— | $ |
Corporate debt securities ................................................................................... | — | ||||
Collateralized debt obligations and collateralized loan obligations ............ | — | ||||
U.S. government and federal agency securities ............................................. | — | ||||
Municipal securities ............................................................................................ | — | ||||
Sovereign obligations ......................................................................................... | — | ||||
Residential mortgage-backed securities ......................................................... | — | ||||
Commercial mortgage-backed securities ....................................................... | — | ||||
Other asset-backed securities ........................................................................... | — | ||||
Loans and other receivables .............................................................................. | — | ||||
Derivatives ............................................................................................................ | ( | ||||
Investments at fair value .................................................................................... | — | ||||
Total financial instruments owned, excluding Investments at fair value based on NAV ................................................................................................. | $ | $ | $ | $( | $ |
Securities segregated and on deposit for regulatory purposes or deposited with clearing and depository organizations ............................ | $ | $ | $ | $— | $ |
Securities received as collateral ....................................................................... | — | ||||
Liabilities: | |||||
Financial instruments sold, not yet purchased: | |||||
Corporate equity securities ................................................................................ | $ | $ | $ | $— | $ |
Corporate debt securities ................................................................................... | — | ||||
U.S. government and federal agency securities ............................................. | — | ||||
Sovereign obligations ......................................................................................... | — | ||||
Residential mortgage-backed securities ......................................................... | — | ||||
Commercial mortgage-backed securities ....................................................... | — | ||||
Loans..................................................................................................................... | — | ||||
Derivatives ............................................................................................................ | ( | ||||
Total financial instruments sold, not yet purchased .................................... | $ | $ | $ | $( | $ |
Other secured financings ................................................................................... | $ | $ | $ | $— | $ |
Obligation to return securities received as collateral .................................... | — | ||||
Long-term debt .................................................................................................... | — | ||||
February 2025 Form 10-Q | 13 |
November 30, 2024 (1) | |||||
$ in thousands | Level 1 | Level 2 | Level 3 | Counterparty and Cash Collateral Netting (2) | Total |
Assets: | |||||
Financial instruments owned: | |||||
Corporate equity securities ................................................................................ | $ | $ | $ | $— | $ |
Corporate debt securities ................................................................................... | — | ||||
Collateralized debt obligations and collateralized loan obligations ............ | — | ||||
U.S. government and federal agency securities ............................................. | — | ||||
Municipal securities ............................................................................................ | — | ||||
Sovereign obligations ......................................................................................... | — | ||||
Residential mortgage-backed securities ......................................................... | — | ||||
Commercial mortgage-backed securities ....................................................... | — | ||||
Other asset-backed securities ........................................................................... | — | ||||
Loans and other receivables .............................................................................. | — | ||||
Derivatives ............................................................................................................ | ( | ||||
Investments at fair value .................................................................................... | — | ||||
Total financial instruments owned, excluding Investments at fair value based on NAV ................................................................................................. | $ | $ | $ | $( | $ |
Securities segregated and on deposit for regulatory purposes or deposited with clearing and depository organizations ............................. | $ | $ | $ | $— | $ |
Securities received as collateral ....................................................................... | — | ||||
Liabilities: | |||||
Financial instruments sold, not yet purchased: | |||||
Corporate equity securities ................................................................................ | $ | $ | $ | $— | $ |
Corporate debt securities ................................................................................... | — | ||||
U.S. government and federal agency securities ............................................. | — | ||||
Sovereign obligations ......................................................................................... | — | ||||
Commercial mortgage-backed securities ...................................................... | — | ||||
Loans..................................................................................................................... | — | ||||
Derivatives ............................................................................................................ | ( | ||||
Total financial instruments sold, not yet purchased .................................... | $ | $ | $ | $( | $ |
Other secured financings ................................................................................... | $ | $ | $ | $— | $ |
Obligation to return securities received as collateral ................................... | — | ||||
Long-term debt .................................................................................................... | — | ||||
14 | Jefferies Financial Group Inc. |
February 28, 2025 | ||||
$ in thousands | Fair Value (1) | Unfunded Commitments | Redemption Frequency | Redemption Notice Period |
Hedge Funds (2) .............. | $ | $ | Quarterly ( Monthly ( | |
Private Equity Funds (3) .............. | N/R ( | N/R | ||
Credit Funds (4) .............. | Quarterly ( Monthly ( N/R ( | N/R | ||
Real Estate and Other Funds (5) .... | Quarterly ( N/R ( | N/R | ||
Total ...................... | $ | $ | ||
November 30, 2024 | ||||
$ in thousands | Fair Value (1) | Unfunded Commitments | Redemption Frequency | Redemption Notice Period |
Hedge Funds (2) ............ | $ | $ | Quarterly ( Monthly ( | |
Private Equity Funds (3) ............ | N/R ( | N/R | ||
Credit Funds (4) | Quarterly ( Monthly ( N/R ( | N/R | ||
Real Estate and Other Funds (5) . | N/R ( | N/R | ||
Total ................... | $ | $ | ||
February 2025 Form 10-Q | 15 |
For instruments still held at February 28, 2025, changes in unrealized gains/(losses) included in: | ||||||||||
$ in thousands | Balance at November 30, 2024 | Total gains/ losses (realized and unrealized) (1) | Purchases | Sales | Settlements | Issuances | Net transfers into/ (out of) Level 3 | Balance at February 28, 2025 | Earnings (1) | Other comprehensive income (1) |
Assets: | ||||||||||
Financial instruments owned: | ||||||||||
Corporate equity securities ... | $ | $ | $ | $( | $ | $ | $( | $ | $ | $ |
Corporate debt securities ...... | ( | ( | ( | ( | ||||||
CDOs and CLOs ....................... | ( | ( | ( | |||||||
Sovereign obligations ............. | ( | ( | ||||||||
RMBS ........................................ | ( | ( | ( | |||||||
CMBS ........................................ | ( | |||||||||
Other ABS ................................. | ( | ( | ( | ( | ( | |||||
Loans and other receivables . | ( | ( | ( | ( | ( | |||||
Investments at fair value ....... | ( | |||||||||
Liabilities: | ||||||||||
Financial instruments sold, not yet purchased: | ||||||||||
Corporate equity securities ... | $ | $( | $ | $ | $ | $ | $ | $ | $ | $ |
Corporate debt securities ...... | ( | ( | ||||||||
RMBS ........................................ | ||||||||||
CMBS ........................................ | ( | ( | ||||||||
Loans ........................................ | ( | ( | ||||||||
Net derivatives (2) ................... | ( | ( | ||||||||
Other secured financings ....... | ( | ( | ||||||||
Long-term debt ........................ | ( | ( | ||||||||
16 | Jefferies Financial Group Inc. |
For instruments still held at February 29, 2024, changes in unrealized gains/(losses) included in: | ||||||||||
$ in thousands | Balance at November 30, 2023 | Total gains/ losses (realized and unrealized) (1) | Purchases | Sales | Settlements | Issuances | Net transfers into/ (out of) Level 3 | Balance at February 29, 2024 | Earnings (1) | Other comprehensive income (1) |
Assets: | ||||||||||
Financial instruments owned: | ||||||||||
Corporate equity securities ....................... | $ | $( | $ | $( | $ | $ | $( | $ | $( | $ |
Corporate debt securities | ( | ( | ( | |||||||
CDOs and CLOs ................. | ( | ( | ( | |||||||
RMBS .................................. | ( | ( | ( | |||||||
CMBS .................................. | ( | ( | ||||||||
Other ABS ........................... | ( | ( | ( | ( | ( | |||||
Loans and other receivables .................... | ( | ( | ( | ( | ( | |||||
Investments at fair value . | ( | ( | ( | |||||||
Liabilities: | ||||||||||
Financial instruments sold, not yet purchased: | ||||||||||
Corporate equity securities ....................... | $ | $( | $ | $ | $ | $ | $ | $ | $ | $ |
Corporate debt securities | ||||||||||
CMBS .................................. | ( | ( | ||||||||
Loans .................................. | ( | ( | ( | |||||||
Net derivatives (2) ............. | ( | |||||||||
Other secured financings . | ( | ( | ||||||||
Long-term debt .................. | ( | |||||||||
February 2025 Form 10-Q | 17 |
February 28, 2025 | |||||||
Financial Instruments Owned | Fair Value (in thousands) | Valuation Technique | Significant Unobservable Input(s) | Input / Range | Weighted Average | ||
Corporate equity securities ..................... | $ | ||||||
Non-exchange-traded securities | Market approach | Price | $ | - | $ | $ | |
Scenario Analysis | EBITDA multiple | — | |||||
Corporate debt securities ........................ | $ | Market approach | Price | $ | - | $ | $ |
Discounted cash flows | Discount rate/yield | — | |||||
CDOs and CLOs .......................................... | $ | Discounted cash flows | Constant prepayment rate | — | |||
Constant default rate | — | ||||||
Loss severity | — | ||||||
Discount rate/yield | - | ||||||
Market approach | Price | $ | - | $ | $ | ||
Scenario analysis | Estimated recovery percentage | — | |||||
RMBS ........................................................... | $ | Discounted cash flows | Constant prepayment rate | — | |||
Loss severity | — | ||||||
Discount rate/yield | — | ||||||
Other ABS ................................................... | $ | Discounted cash flows | Discount rate/yield | - | |||
Cumulative loss rate | - | ||||||
Duration (years) | - | ||||||
Market approach | Price | $ | - | $ | $ | ||
Scenario analysis | Estimated recovery percentage | — | |||||
Loans and other receivables ................... | $ | Market approach | Price | $ | - | $ | $ |
Scenario analysis | Estimated recovery percentage | - | |||||
Derivatives .................................................. | $ | ||||||
Embedded options | Market approach | Basis points upfront | — | ||||
Investments at fair value .......................... | $ | ||||||
Private equity securities | Market approach | Price | $ | - | $ | $ | |
Discount rate/yield | — | ||||||
Revenue | $ | — | |||||
Financial Instruments Sold, Not Yet Purchased: | |||||||
Loans .......................................................... | $ | Market approach | Price | $ | - | $ | $ |
Derivatives .................................................. | $ | ||||||
Equity options | Volatility benchmarking | Volatility | - | ||||
Options | Market approach | Basis points upfront | - | ||||
Other secured financings ......................... | $ | Scenario analysis | Estimated recovery percentage | - | |||
Market approach | Price | $ | — | ||||
Long-term debt .......................................... | $ | ||||||
Structured notes | Market approach | Price | $ | - | $ | $ | |
18 | Jefferies Financial Group Inc. |
November 30, 2024 | |||||||
Financial Instruments Owned | Fair Value (in thousands) | Valuation Technique | Significant Unobservable Input(s) | Input / Range | Weighted Average | ||
Corporate equity securities ..................... | $ | ||||||
Non-exchange-traded securities | Market approach | Price | $ | - | $ | $ | |
Corporate debt securities ........................ | $ | Market approach | Price | $ | - | $ | $ |
CDOs and CLOs .......................................... | $ | Discounted cash flows | Constant prepayment rate | — | |||
Constant default rate | — | ||||||
Loss severity | — | ||||||
Discount rate/yield | - | ||||||
Market approach | Price | $ | - | $ | $ | ||
RMBS | $ | Discounted cash flows | Constant prepayment rate | — | |||
Loss severity | — | ||||||
Discount rate/yield | — | ||||||
Other ABS ................................................... | $ | Discounted cash flows | Discount rate/yield | - | |||
Cumulative loss rate | - | ||||||
Duration (years) | - | ||||||
Market approach | Price | $ | - | $ | $ | ||
Scenario analysis | Estimated recovery percentage | — | |||||
Loans and other receivables ................... | $ | Market approach | Price | $ | - | $ | $ |
Scenario analysis | Estimated recovery percentage | - | |||||
Derivatives .................................................. | $ | ||||||
Embedded options | Market approach | Basis points upfront | — | ||||
Investments at fair value .......................... | $ | ||||||
Private equity securities | Market approach | Price | $ | - | $ | $ | |
Discount rate/yield | — | ||||||
Revenue | $ | — | |||||
Financial Instruments Sold, Not Yet Purchased: | |||||||
Loans .......................................................... | $ | Market approach | Price | $ | - | $ | $ |
Scenario analysis | Estimated recovery percentage | - | |||||
Derivatives .................................................. | $ | ||||||
Equity options | Volatility benchmarking | Volatility | - | ||||
Options | Market approach | Basis points upfront | - | ||||
Other secured financings ......................... | $ | Scenario analysis | Estimated recovery percentage | - | |||
Market approach | Price | $ | — | ||||
Long-term debt .......................................... | $ | ||||||
Structured notes | Market approach | Price | $ | - | $ | $ | |
February 2025 Form 10-Q | 19 |
Three Months Ended | ||
$ in thousands | February 28, 2025 | February 29, 2024 |
Financial instruments owned: | ||
Loans and other receivables ................................ | $ | $( |
Other secured financings: | ||
Other changes in fair value (2) ............................. | $ | $( |
Long-term debt: | ||
Changes in instrument-specific credit risk (1) .. | $ | $( |
Other changes in fair value (2) ............................. | ( | |
$ in thousands | February 28, 2025 | November 30, 2024 |
Financial instruments owned: | ||
Loans and other receivables (1) ........................... | $ | $ |
Loans and other receivables on nonaccrual status and/or 90 days or greater past due (1) (2) ........................................................... | ||
Long-term debt ....................................................... | ||
Other secured financings ...................................... |
20 | Jefferies Financial Group Inc. |
February 28, 2025 (1) | ||||
Assets | Liabilities | |||
$ in thousands | Fair Value | Number of Contracts (2) | Fair Value | Number of Contracts (2) |
Derivatives designated as accounting hedges: | ||||
Interest rate contracts: | ||||
Cleared OTC ........................................ | $ | $ | ||
Foreign exchange contracts: | ||||
Bilateral OTC ....................................... | ||||
Total derivatives designated as accounting hedges ............................ | ||||
Derivatives not designated as accounting hedges: | ||||
Interest rate contracts: | ||||
Exchange-traded ................................ | ||||
Cleared OTC ........................................ | ||||
Bilateral OTC ....................................... | ||||
Foreign exchange contracts: | ||||
Bilateral OTC ....................................... | ||||
Equity contracts: | ||||
Exchange-traded ................................ | ||||
Bilateral OTC ....................................... | ||||
Commodity contracts: | ||||
Exchange-traded ................................ | ||||
Bilateral OTC ....................................... | ||||
Credit contracts: | ||||
Cleared OTC ........................................ | ||||
Bilateral OTC ....................................... | ||||
Total derivatives not designated as accounting hedges ....................... | ||||
Total gross derivative assets/ liabilities: | ||||
Exchange-traded ................................ | ||||
Cleared OTC ........................................ | ||||
Bilateral OTC ....................................... | ||||
Amounts offset in our Consolidated Statements of Financial Condition (3): | ||||
Exchange-traded ................................ | ( | ( | ||
Cleared OTC ........................................ | ( | ( | ||
Bilateral OTC ....................................... | ( | ( | ||
Net amounts per Consolidated Statements of Financial Condition (4) ................................. | $ | $ | ||
February 2025 Form 10-Q | 21 |
November 30, 2024 (1) | ||||
Assets | Liabilities | |||
$ in thousands | Fair Value | Number of Contracts (2) | Fair Value | Number of Contracts (2) |
Derivatives designated as accounting hedges: | ||||
Interest rate contracts: | ||||
Cleared OTC ......................................... | $ | $ | ||
Foreign exchange contracts: | ||||
Bilateral OTC ........................................ | ||||
Total derivatives designated as accounting hedges ............................. | ||||
Derivatives not designated as accounting hedges: | ||||
Interest rate contracts: | ||||
Exchange-traded ................................. | ||||
Cleared OTC ......................................... | ||||
Bilateral OTC ........................................ | ||||
Foreign exchange contracts: | ||||
Bilateral OTC ........................................ | ||||
Equity contracts: | ||||
Exchange-traded ................................. | ||||
Bilateral OTC ........................................ | ||||
Commodity contracts: | ||||
Exchange-traded ................................. | ||||
Bilateral OTC ....................................... | ||||
Credit contracts: | ||||
Cleared OTC ......................................... | ||||
Bilateral OTC ........................................ | ||||
Total derivatives not designated as accounting hedges ............................. | ||||
Total gross derivative assets/ liabilities: | ||||
Exchange-traded ................................. | ||||
Cleared OTC ......................................... | ||||
Bilateral OTC ........................................ | ||||
Amounts offset in our Consolidated Statements of Financial Condition (3): | ||||
Exchange-traded ................................. | ( | ( | ||
Cleared OTC ......................................... | ( | ( | ||
Bilateral OTC ........................................ | ( | ( | ||
Net amounts per Consolidated Statements of Financial Condition (4) .................................. | $ | $ | ||
$ in thousands | Three Months Ended | |
Gains (Losses) | February 28, 2025 | February 29, 2024 |
Interest rate swaps (1) ................................................ | $( | $( |
Long-term debt ............................................................. | ( | ( |
Total ............................................................................... | $( | $( |
$ in thousands | Three Months Ended | |
Gains (Losses) | February 28, 2025 | February 29, 2024 |
Foreign exchange contracts ....................................... | $ | $ |
Total ............................................................................... | $ | $ |
$ in thousands | Three Months Ended | |
Gains (Losses) | February 28, 2025 | February 29, 2024 |
Interest rate contracts ................................................. | $( | $ |
Foreign exchange contracts ....................................... | ( | ( |
Equity contracts ........................................................... | ( | |
Commodity contracts .................................................. | ||
Credit contracts ............................................................ | ( | |
Total ............................................................................... | $ | $( |
22 | Jefferies Financial Group Inc. |
OTC Derivative Assets (1) (2) (3) | |||||
$ in thousands | 0 – 12 Months | 1 – 5 Years | Greater Than 5 Years | Cross- Maturity Netting (4) | Total |
Commodity swaps, options and forwards ...................................... | $ | $ | $ | $ | $ |
Equity options and forwards .......... | |||||
Credit default swaps ....................... | |||||
Total return swaps ........................... | ( | ||||
Foreign currency forwards, swaps and options ................................. | |||||
Fixed income forwards ................... | |||||
Interest rate swaps, options and forwards ...................................... | ( | ||||
Total ................................................... | $ | $ | $ | $( | |
Cross-product counterparty netting .......................................... | ( | ||||
Total OTC derivative assets included in Financial instruments owned .................... | $ | ||||
OTC Derivative Liabilities (1) (2) (3) | |||||
$ in thousands | 0 – 12 Months | 1 – 5 Years | Greater Than 5 Years | Cross- Maturity Netting (4) | Total |
Commodity swaps, options and forwards ...................................... | $ | $ | $ | $ | $ |
Equity options and forwards .......... | |||||
Credit default swaps ........................ | |||||
Total return swaps ........................... | ( | ||||
Foreign currency forwards, swaps and options ................................. | |||||
Fixed income forwards ................... | |||||
Interest rate swaps, options and forwards ...................................... | ( | ||||
Total ................................................... | $ | $ | $ | $( | |
Cross-product counterparty netting .......................................... | ( | ||||
Total OTC derivative liabilities included in Financial instruments sold, not yet purchased ................................... | $ | ||||
Counterparty credit quality (1): | $ in thousands |
A- or higher ............................................................................................... | $ |
BBB- to BBB+ ........................................................................................... | |
BB+ or lower ............................................................................................. | |
Unrated ..................................................................................................... | |
Total .......................................................................................................... | $ |
February 28, 2025 | |||
External Credit Rating | |||
$ in millions | Investment Grade | Non- investment Grade | Total Notional |
Credit protection sold: | |||
Index credit default swaps ..................... | $ | $ | $ |
November 30, 2024 | |||
External Credit Rating | |||
$ in millions | Investment Grade | Non- investment Grade | Total Notional |
Credit protection sold: | |||
Index credit default swaps ..................... | $ | $ | $ |
$ in millions | February 28, 2025 | November 30, 2024 |
Derivative instrument liabilities with credit-risk- related contingent features ................................... | $ | $ |
Collateral posted .......................................................... | ( | ( |
Collateral received ....................................................... | ||
Return of and additional collateral required in the event of a credit rating downgrade below investment grade (1) .............................................. |
February 2025 Form 10-Q | 23 |
February 28, 2025 | ||||
$ in millions | Securities Lending Arrangements | Repurchase Agreements | Obligation to Return Securities Received as Collateral, at Fair Value | Total |
Collateral Pledged: | ||||
Corporate equity securities ..................... | $ | $ | $ | $ |
Corporate debt securities ..................... | ||||
Mortgage-backed and asset-backed securities ..................... | ||||
U.S. government and federal agency securities ..................... | ||||
Municipal securities ........ | ||||
Sovereign obligations ..... | ||||
Loans and other receivables .................. | ||||
Total .................................. | $ | $ | $ | $ |
November 30, 2024 | ||||
$ in millions | Securities Lending Arrangements | Repurchase Agreements | Obligation to Return Securities Received as Collateral, at Fair Value | Total |
Collateral Pledged: | ||||
Corporate equity securities ..................... | $ | $ | $ | $ |
Corporate debt securities ..................... | ||||
Mortgage-backed and asset-backed securities ..................... | ||||
U.S. government and federal agency securities ..................... | ||||
Municipal securities ........ | ||||
Sovereign obligations ..... | ||||
Loans and other receivables .................. | ||||
Total .................................. | $ | $ | $ | $ |
February 28, 2025 | |||||
$ in millions | Overnight and Continuous | Up to 30 Days | 31-90 Days | Greater than 90 Days | Total |
Securities lending arrangements .............. | $ | $ | $ | $ | $ |
Repurchase agreements . | |||||
Obligation to return securities received as collateral, at fair value ............................. | |||||
Total ................................... | $ | $ | $ | $ | $ |
November 30, 2024 | |||||
$ in millions | Overnight and Continuous | Up to 30 Days | 31-90 Days | Greater than 90 Days | Total |
Securities lending arrangements .............. | $ | $ | $ | $ | $ |
Repurchase agreements . | |||||
Obligation to return securities received as collateral, at fair value ............................. | |||||
Total ................................... | $ | $ | $ | $ | $ |
24 | Jefferies Financial Group Inc. |
February 28, 2025 | ||||||
$ in millions | Gross Amounts | Netting in Consolidated Statements of Financial Condition | Net Amounts in Consolidated Statements of Financial Condition | Additional Amounts Available for Setoff (1) | Available Collateral (2) | Net Amount (3) |
Assets: | ||||||
Securities borrowing arrangements ................................... | $ | $ | $ | $( | $( | $ |
Reverse repurchase agreements ......................................... | ( | ( | ( | |||
Securities received as collateral, at fair value ................... | ( | |||||
Liabilities: | ||||||
Securities lending arrangements ........................................ | $ | $ | $ | $( | $( | $ |
Repurchase agreements ....................................................... | ( | ( | ( | |||
Obligation to return securities received as collateral, at fair value ............................................................................. | ( | |||||
November 30, 2024 | ||||||
$ in millions | Gross Amounts | Netting in Consolidated Statements of Financial Condition | Net Amounts in Consolidated Statements of Financial Condition | Additional Amounts Available for Setoff (1) | Available Collateral (2) | Net Amount (4) |
Assets: | ||||||
Securities borrowing arrangements ................................... | $ | $ | $ | $( | $( | $ |
Reverse repurchase agreements ......................................... | ( | ( | ( | |||
Securities received as collateral, at fair value ................... | ( | |||||
Liabilities: | ||||||
Securities lending arrangements ........................................ | $ | $ | $ | $( | $( | $ |
Repurchase agreements ....................................................... | ( | ( | ( | |||
Obligation to return securities received as collateral, at fair value ............................................................................. | ( | |||||
February 2025 Form 10-Q | 25 |
$ in millions | February 28, 2025 | November 30, 2024 |
Cash and securities segregated and on deposit for regulatory purposes or deposited with clearing and depository organizations ................... | $ | $ |
Three Months Ended | ||
$ in millions | February 28, 2025 | February 29, 2024 |
Transferred assets ..................................................... | $ | $ |
Proceeds on new securitizations ............................. | ||
Cash flows received on retained interests .............. | ||
$ in millions | February 28, 2025 | November 30, 2024 | ||
Securitization Type | Total Assets | Retained Interests | Total Assets | Retained Interests |
U.S. government agency RMBS ... | $ | $ | $ | $ |
U.S. government agency CMBS ... | ||||
CLOs ................................................. | ||||
Consumer and other loans ........... | ||||
26 | Jefferies Financial Group Inc. |
February 28, 2025 (1) | ||
$ in millions | Secured Funding Vehicles | Other |
Cash ................................................................................... | $ | $ |
Financial instruments owned ........................................ | ||
Securities purchased under agreements to resell (2) | ||
Receivables from brokers (3) ......................................... | ||
Other receivables ............................................................. | ||
Other assets (4) ............................................................... | ||
Total assets ...................................................................... | $ | $ |
Financial instruments sold, not yet purchased ........... | $ | $ |
Other secured financings (5) ......................................... | ||
Other liabilities (6) ........................................................... | ||
Long-term debt ................................................................ | ||
Total liabilities ................................................................. | $ | $ |
November 30, 2024 (1) | ||
$ in millions | Secured Funding Vehicles | Other |
Cash ................................................................................... | $ | $ |
Financial instruments owned ......................................... | ||
Securities purchased under agreements to resell (2) | ||
Receivables from brokers (3) ......................................... | ||
Other receivables ............................................................. | ||
Other assets (4) ............................................................... | ||
Total assets ...................................................................... | $ | $ |
Financial instruments sold, not yet purchased ........... | $ | $ |
Other secured financings (5) ......................................... | ||
Other liabilities (6) ........................................................... | ||
Long-term debt ................................................................ | ||
Total liabilities ................................................................. | $ | $ |
February 2025 Form 10-Q | 27 |
February 28, 2025 | ||||
Carrying Amount | Maximum Exposure to Loss | VIE Assets | ||
$ in millions | Assets | Liabilities | ||
CLOs ...................................... | $ | $ | $ | $ |
Asset-backed vehicles ........ | ||||
Related party private equity vehicles ............................ | ||||
Other investment vehicles .. | ||||
Total ....................................... | $ | $ | $ | $ |
November 30, 2024 | ||||
Carrying Amount | Maximum Exposure to Loss | VIE Assets | ||
$ in millions | Assets | Liabilities | ||
CLOs ...................................... | $ | $ | $ | |
Asset-backed vehicles ........ | ||||
Related party private equity vehicles ............................ | ||||
Other investment vehicles .. | ||||
Total ....................................... | $ | $ | $ | $ |
28 | Jefferies Financial Group Inc. |
$ in millions | February 28, 2025 | November 30, 2024 |
Total Investments in and loans to related parties ........................................................ | $ | $ |
Three Months Ended | ||
$ in millions | February 28, 2025 | February 29, 2024 |
Total equity method pickup earnings recognized in Other revenues .................................................... | $ | $ |
Three Months Ended | ||
$ in millions | February 28, 2025 | February 29, 2024 |
Unfunded commitment fees ....................................... | $ | $ |
$ in millions | February 28, 2025 | November 30, 2024 |
Total assets .................................................... | $ | $ |
Total liabilities ................................................ | ||
Total mezzanine equity ................................. |
$ in millions | February 28, 2025 | November 30, 2024 |
Our total investment balance ....................... | $ | $ |
Three Months Ended | ||
$ in millions | February 28, 2025 | February 29, 2024 |
Net earnings (losses) attributable to members ........ | $( | $ |
February 2025 Form 10-Q | 29 |
Three Months Ended | ||
$ in millions | February 28, 2025 | February 29, 2024 |
Origination and syndication fee revenues (1) .......... | $ | $ |
Origination fee expenses (1) ...................................... | ||
CLO placement and structuring fee revenues (2) .. | ||
Investment fund placement fee revenues (3) ........... | ||
Service fees (4) ............................................................. | ||
$ in millions | February 28, 2025 | November 30, 2024 |
Total assets ................................................... | $ | $ |
Total liabilities ............................................... | ||
Total noncontrolling interest ....................... |
$ in millions | February 28, 2025 | November 30, 2024 |
Our total investment balance ....................... | $ | $ |
Three Months Ended | ||
$ in millions | February 28, 2025 | February 29, 2024 |
Net earnings attributable to members ...................... | $ | $ |
Three Months Ended | ||
$ in millions | February 28, 2025 | February 29, 2024 |
Distributions .................................................................. | $ | $ |
Three Months Ended | ||
$ in millions | February 28, 2025 | February 29, 2024 |
Transaction referral fee revenue (1) .......................... | $ | $ |
$ in millions | February 28, 2025 | November 30, 2024 |
Total assets .................................................... | $ | $ |
Total liabilities ................................................ | ||
February 28, 2025 | November 30, 2024 | |
Our total investment balance ....................... | $ | $ |
Three Months Ended | ||
$ in millions | February 28, 2025 | February 29, 2024 |
Net earnings .................................................................. | $ | $ |
30 | Jefferies Financial Group Inc. |
Three Months Ended | ||
$ in millions | February 28, 2025 | February 29, 2024 |
Net losses from our investments in JCP Fund V ...... | $( | $( |
Three Months Ended December 31, | ||
$ in millions | 2024 | 2023 |
Net decrease in net assets resulting from operations (1) .......................................................... | $( | $( |
$ in millions | December 31, 2024 (1) | September 30, 2024 (1) |
Total assets .................................................... | $ | $ |
Total liabilities ................................................ | ||
Total members’ equity .................................. |
$ in millions | Three Months Ended December 31, 2024 (1) |
Net increase in members’ equity resulting from operations ....... | $ |
February 2025 Form 10-Q | 31 |
Three Months Ended | ||
$ in thousands | February 28, 2025 | February 29, 2024 |
Beginning balance ............................................. | $ | $6,306 |
Bad debt expense .............................................. | 1,011 | |
Charge-offs ......................................................... | ( | (2,500) |
Recoveries collected ......................................... | ( | (1,854) |
Ending balance (1) ............................................. | $ | $ |
Three Months Ended February 28, 2025 | |||
$ in thousands | Investment Banking and Capital Markets | Asset Management | Total |
Balance, at beginning of period ................... | $ | $ | $ |
Currency translation and other adjustments .............................................. | ( | ( | ( |
Balance, at end of period ............................. | $ | $ | $ |
Three Months Ended February 29, 2024 | |||
$ in thousands | Investment Banking and Capital Markets | Asset Management | Total |
Balance, at beginning of period ................... | $ | $ | $ |
Currency translation and other adjustments .............................................. | ( | ( | |
Measurement period adjustments (1) ........ | ( | ( | |
Goodwill relating to acquisitions by Tessellis ..................................................... | |||
Balance, at end of period ............................. | $ | $ | $ |
$ in millions | February 28, 2025 | November 30, 2024 |
Investment banking ............................................................. | $ | $ |
Equities and wealth management ..................................... | ||
Fixed income ........................................................................ | ||
Asset management ............................................................. | ||
Other investments ............................................................... | ||
Total ...................................................................................... | $ | $ |
February 28, 2025 | Weighted Average Remaining Lives (Years) | ||||
$ in thousands | Gross Cost | Assets Acquired | Accumulated Amortization | Net Carrying Amount | |
Customer relationships ....................... | $ | $ | $( | $ | |
Trademarks and trade names ............ | ( | ||||
Exchange and clearing organization membership interests and registrations .......................................... | — | N/A | |||
Other ...................................................... | ( | ||||
Total ....................................................... | $ | $ | $( | $ | |
November 30, 2024 | Weighted Average Remaining Lives (Years) | |||||
$ in thousands | Gross Cost | Assets Acquired (1) | Impairment Losses | Accumulated Amortization | Net Carrying Amount | |
Customer relationships | $ | $ | $ | $( | $ | |
Trademarks and trade names .............................. | ( | |||||
Exchange and clearing organization membership interests and registrations ............ | ( | — | N/A | |||
Other ................................ | ( | |||||
Total ................................ | $ | $ | $( | $( | $ | |
32 | Jefferies Financial Group Inc. |
Remainder of fiscal year 2025 ................................................................ | $ |
Year ending November 30, 2026 ............................................................ | |
Year ending November 30, 2027 ............................................................ | |
Year ending November 30, 2028 ............................................................ | |
Year ending November 30, 2029 ............................................................ |
Three Months Ended | ||
$ in thousands | February 28, 2025 | February 29, 2024 |
Revenues from contracts with customers: | ||
Investment banking ..................................................... | $ | $ |
Commissions and other fees .................................... | ||
Asset management fees ............................................. | ||
Real estate revenues ................................................... | ||
Internet connection and broadband revenues (1) ... | ||
Other contracts with customers ................................ | ||
Total revenue from contracts with customers ....... | ||
Other sources of revenue: | ||
Principal transactions .................................................. | ||
Revenues from strategic affiliates ............................ | ||
Interest ........................................................................... | ||
Other (1) ......................................................................... | ||
Total revenues ............................................................. | $ | $ |
Three Months Ended February 28, 2025 | |||
$ in thousands | Investment Banking and Capital Markets | Asset Management | Total |
Major business activity: | |||
Investment banking - Advisory ................ | $ | $ | $ |
Investment banking - Underwriting ......... | |||
Equities (1) ................................................. | |||
Fixed income (1) ........................................ | |||
Asset management ................................... | |||
Other investments ..................................... | |||
Total | |||